Maintaining therapeutic activity in the operating room: compatibility of a gamma-retroviral replicating vector with clinical materials and biofluids

Toca 511 is a novel retroviral replicating vector, encoding a modified yeast cytosine deaminase, administered to recurrent high grade glioma patients in Phase 1 trials by stereotactic, transcranial injection into the tumor or into the walls of the resection cavity. A key issue, with little published...

Descripción completa

Detalles Bibliográficos
Autores principales: Burnett, Ryan, Ibañez, Carlos E., Pettersson, Pär L., Chen, Ching-I, Parab, Shraddha, Huang, Tiffany, Robbins, Joan, Bankiewicz, Krystof, Aghi, Manish, Logg, Christopher, Kasahara, Noriyuki, Pertschuk, Dan, Gruber, Harry E., Jolly, Douglas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362351/
https://www.ncbi.nlm.nih.gov/pubmed/26015967
http://dx.doi.org/10.1038/mtm.2014.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362351/
https://www.ncbi.nlm.nih.gov/pubmed/26015967
http://dx.doi.org/10.1038/mtm.2014.24

Ejemplares similares